The variation in COVID-19 disease severity may be explained, in part, by different antibody signatures. Researchers found that levels of specific types of antibodies may be driving different responses, including one specific to severe disease in adults and another specific to MIS-C in children. Discovering how the immune system’s response shapes COVID-19 and its outcome can help researchers develop treatments based on modulating the immune response.
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed